SCHEMBL321771

SCHEMBL321771

Cc1ccccc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.56
AR P10275 1/20 0.50
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
ALDH1A1 P00352 2/20 0.46
TSHR P16473 1/20 0.46
PDK2 Q15119 1/20 0.46
BACE1 P56817 2/20 0.45
MAPT P10636 4/20 0.44
TP53 P04637 2/20 0.44
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12388145 0.86 CA12 (0.46) KIF11ARCA12CA1CA2
SCHEMBL12388711 0.86 CA12 (0.46) KIF11ARCA12CA1CA2
SCHEMBL26375017 0.85 AR (0.49) KIF11ARCA12CA1CA2
SCHEMBL17840160 0.84 KIF11 (0.68) KIF11ALDH1A1TSHRBACE1KDM4E
SCHEMBL10304776 0.84 KIF11 (0.47) KIF11ALDH1A1TSHRBACE1MAPT
SCHEMBL12364956 0.84 CA12 (0.44) KIF11ARCA12CA1CA2
SCHEMBL10304812 0.82 KIF11 (0.45) KIF11BACE1MAPTTP53RAB9A
SCHEMBL8025255 0.82 KIF11 (0.65) KIF11ALDH1A1TSHRBACE1KDM4E
SCHEMBL3633054 0.82 CA12 (0.61) ARCA12CA1CA2CA9
SCHEMBL29551674 0.82 CA12 (0.61) ARCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP claimed
EP-1700837-B1 Process for producing 4-(2-methylphenyl)benzotrifluoride SUMITOMO CHEMICAL CO (JP) 2008-09-03 EP claimed
US-7208645-B2 Process for producing 4-(2-methylphenyl)benzotrifluoride SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-24 US claimed
US-20060211896-A1 Process for producing 4-(2-methylphenyl)benzotrifluoride SUMITOMO CHEMICAL COMPANY, LIMITED 2006-09-21 US claimed
EP-1700837-A1 Process for producing 4-(2-methylphenyl)benzotrifluoride Sumitomo Chemical Company, Limited (JP) 2006-09-13 EP claimed
CN-113845427-B Aryl alcohol, aryl ketone, aryl carboxylic acid compound, and synthetic method and application thereof 华东师范大学 2024-06-25 CN disclosed
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 US disclosed
CN-115433076-A Method for preparing aromatic acid by metal-free photocatalytic oxidation 浙江工业大学 2022-12-06 CN disclosed
CN-111978200-B Biphenylamide derivative, preparation method and application 湖北省生物农药工程研究中心 2022-09-13 CN disclosed
CN-113845427-A Aryl alcohol, aryl ketone, aryl carboxylic acid compound and synthesis method and application thereof 华东师范大学 2021-12-28 CN disclosed
US-11193065-B2 Liquid crystal composition, method of producing the same, and retardation film constituted from the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-12-07 US disclosed
EP-3719004-A1 PYRIDINIUM SALT AND PEST CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2020-10-07 EP disclosed
US-20010034459-A1 Process for preparing 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethyl-biphenyl-2-carboxylic acid from o-tolylmetallates MEUDT ANDREAS (DE) 2001-10-25 US disclosed
US-20010034459-A1 Process for preparing 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethyl-biphenyl-2-carboxylic acid from o-tolylmetallates MEUDT ANDREAS (DE) 2001-10-25 US disclosed
US-20010020110-A1 Production methods of alpha, alpha, alpha-trifluoromethylphenyl-substituted benzoic acid and intermediate therefor SUMIKA FINE CHEMICALS CO., LTD. (JP) 2001-09-06 US disclosed
EP-1122234-A2 Production methods of alpha, alpha, alpha-trifluoromethylphenyl-substituted benzoic acid and intermediate therefor SUMIKA FINE CHEMICALS Co., Ltd. (JP) 2001-08-08 EP disclosed
JP-2001213817-A METHOD OF PRODUCING 4'-TRIFLUOROMETHYL-2-METHYLBIPHENYL AND 4'-TRIFLUOROMETHYL-BIPHENYL-2-CARBOXYLIC ACID FROM O-TOLYL METALATE CLARIANT GMBH 2001-08-07 JP disclosed
EP-1112991-A2 Process for the preparation of 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethylbiphenyl-2-carboxylic acid from o-tolylmetallates Clariant GmbH (DE) 2001-07-04 EP disclosed
EP-1112991-A2 Process for the preparation of 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethylbiphenyl-2-carboxylic acid from o-tolylmetallates Clariant GmbH (DE) 2001-07-04 EP disclosed
EP-1112991-A2 Process for the preparation of 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethylbiphenyl-2-carboxylic acid from o-tolylmetallates Clariant GmbH (DE) 2001-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034459-A1 Process for preparing 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethyl-biphenyl-2-carboxylic acid from o-tolylmetallates ZC3HAV1L, ZRANB2, ZFP3 KIF11 707/4885AR 3505/4885CA12 2343/4885
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE OCIAD1, OCIAD2, SLCO4C1 KIF11 755/4885AR 1888/4885CA12 3711/4885
US-20010020110-A1 Production methods of alpha, alpha, alpha-trifluoromethylphenyl-substituted benzoic acid and intermediate therefor SLC6A11, CYP4F11, SLC39A11 KIF11 1001/4885AR 4294/4885CA12 1460/4885
US-20060211896-A1 Process for producing 4-(2-methylphenyl)benzotrifluoride CYP4F12, GTF3C4, CXXC4 KIF11 1224/4885AR 4688/4885CA12 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.